Anavex Life Sciences Corp (AVXL)

[poguemahone]

Falconer66a:

No disrespect, but the stock price is still on the lower side of its 52 week range, so I don't think we should exactly be doing cartwheels here. In fact, there were several members cheer-leading on this board that after CTAD, after the FDA had given clearance to the "21st Century Cures Act" and after the "roadshow" where we were going to announce partnerships, trial starts, fast track status, and so on and so forth that this stock would be heading towards double digits.

We're not even close to that right now, so I think some reflection needs to be done on what we THOUGHT would happen, what HAS happened, and what we EXPECT to happen next year (and I mean EARLY 2018). To suggest that people overreacted, or that shareholders are impatient because the company made some forward looking statements that turned out to be wrong/misleading/obtuse is not the fault of the shareholders (both retail and institutional). Hopefully Missling has learned some lessons this year about what he should/should not say without being more certain he (or the FDA) can follow through.

Remember--the market is up 27% this year, and AVXL is down 40%. I get that it's biotech, but I don't think ANYONE last January predicted that (unless if you were short). In fact, there were some ludicrous forecasts of prices ranging from $10-$400, depending upon how delusional that person was. I'll be delighted if we can get this price into the low double digits next year ($10-$14)--I'd be extremely happen with that given the current market value. That would value the company around 500 million. That doesn't seem too far fetched if all the pieces begin to fall into place.